Conferences & Events > Annual Scientific Meeting > Program > Speaker Bios

2019 Annual Scientific Meeting and Satellite Sessions - Speakers

New Frontiers in Medical Toxicology: Pharmacogenomics and Precision Medicine

Russ B. Altman, MD, PhD

Professor of Bioengineering, Genetics, Medicine, and Biomedical Data Science, Stanford University

altman.jpegRuss Biagio Altman is a professor of bioengineering, genetics, medicine, and biomedical data science (and of computer science, by courtesy) and past chairman of the Bioengineering Department at Stanford University. His primary research interests are in the application of computing and informatics technologies to problems relevant to medicine. He is particularly interested in methods for understanding drug action at molecular, cellular, organism and population levels. His lab studies how human genetic variation impacts drug response (e.g., Other work focuses on the analysis of biological molecules to understand the actions, interactions and adverse events of drugs (e.g., He helps lead an FDA-supported Center of Excellence in Regulatory Science & Innovation.

Dr. Altman holds an AB from Harvard College, and an MD from Stanford Medical School, and a PhD in Medical Information Sciences from Stanford. He received the U.S. Presidential Early Career Award for Scientists and Engineers and a National Science Foundation CAREER Award. He is a fellow of the American College of Physicians (ACP), the American College of Medical Informatics (ACMI), the American Institute of Medical and Biological Engineering (AIMBE), and the American Association for the Advancement of Science (AAAS). He is a member of the National Academy of Medicine (formerly the Institute of Medicine, IOM). He is a past-president, founding board member, and a fellow of the International Society for Computational Biology (ISCB), and a past-president of the American Society for Clinical Pharmacology & Therapeutics (ASCPT). He has chaired the Science Board advising the FDA commissioner, currently serves on the NIH Director’s Advisory Committee, and is cochair of the IOM Drug Forum. He is an organizer of the annual Pacific Symposium on Biocomputing, and a founder of Personalis, Inc. Dr. Altman is board certified in Internal Medicine and in Clinical Informatics. He received the Stanford Medical School graduate teaching award in 2000 and mentorship award in 2014.

Kelly Caudle, PharmD, PhD

CPIC Director, St. Judes Children's Research Hospital

caudle.jpgKelly E. Caudle, Pharm.D., Ph.D., BCPS is the Clinical Pharmacogenetics Implementation Consortium (CPIC) Director. CPIC provides guidelines that enable the translation of genetic laboratory test results into actionable prescribing decisions for specific drugs. To date, CPIC has published 21 gene-based clinical guidelines. In this position, Dr. Caudle oversees the CPIC guideline development process including the coordination of the guideline writing committees, the guideline evidence reviews, and the writing of the guideline manuscript and supplement. Furthermore, Dr. Caudle is involved in the clinical implementation of pharmacogenetics at St. Jude Children's Research Hospital.

Dr. Caudle received her Pharm.D. and Ph.D. from The University of Tennessee Health Science Center and completed an ASHP-accredited PGY2 residency at Le Bonheur Children’s Research Hospital. She is also a board‐certified Pharmacotherapy Specialist. Dr. Caudle is currently an affiliate Assistant Professor at The University of Tennessee Health Science Center.

Steven Curry, MD

Professor of Emergency Medicine, Internal Medicine and Biomedical Informatics

no_avatar.jpgComing soon.

Will Heise, MD

Assistant Professor, University of Arizona College of Medicine - Phoenix

heise.jpgWill Heise, MD, is a medical toxicologist and family physician. He earned his MD from the University of Iowa. He completed a residency in family medicine and a fellowship in medical toxicology at Banner – University Medical Center Phoenix. His teaching and research interests include critical care toxicology, precision medicine and clinical decision support. He practices with the Department of Medical Toxicology at Banner – University Medical Center and Phoenix Children’s Hospital. He directs the Precision Medicine Theme at the College of Medicine – Phoenix.

Teri Klein, PhD

Professor of Biomedical Data Science and Medicine, Standford University

no_avatar.jpgComing soon

Teri Manolio, MD, PhD

Director, Division of Genomic Medicine, National Human Genome Research Institute

no_avatar.jpgDr. Manolio directs NHGRI’s Division of Genomic Medicine, where she leads programs to develop and implement genomic applications in clinical care. She came to NHGRI from the National Heart, Lung, and Blood Institute where she was heavily involved in large cohort studies such as the Cardiovascular Health Study, the Framingham Heart Study, and the Multi-Ethnic Study of Atherosclerosis. She moved to NHGRI in 2005 to lead efforts in applying genomic technologies to population research, including the Electronic Medical Records and Genetics (eMERGE) Network, the NHGRI Genome-Wide Association Catalog, the Implementing Genomics in Practice (IGNITE) Network, and the Clinical Genome (ClinGen) Resource. She continues to practice and teach internal medicine at the Walter Reed National Military Medical Center and the Uniformed Services University of the Health Sciences.  She is the author of over 280 research publications and has research interests in genome-wide association studies of complex diseases, ethnic differences in disease risk, and incorporating genomic findings into clinical care.

Andrew Monte, MD, PhD

Associate Professor Emergency Medicine and Medical Toxicology, University of Colorado 

Monte.jpgDr. Monte performs research in drug effectiveness and safety in acute care settings. He directs the Emergency Medicine Specimen Bank, which aims to consent and enroll every patient seen in the University of Colorado Emergency Department to improve the way Emergency Medicine is practiced. He coordinates the Pgx Dissemination Working Group in an effort to improve awareness of PGx resources available through groups such as CPIC, PharmGKB, PharmVar, and the PGRN. Additionally, Dr. Monte's research examines the public health impacts of substance abuse though integration of clinical data available through a robust data warehouse linked with biologic samples gathered through his research program. Dr. Monte has expertise in genetics, assay development, and data integration.

Shaun R. Opie, PhD

CEO & CSO, UniversalDx

opie.jpgShaun Opie, PhD is a co-founder and CEO/CSO of UniversalDx, a privately held CLIA and CAP accredited, high-complexity laboratory that offers genomic, toxicology, and routine clinical testing to health care providers. He is responsible for technology assessments, strategic partnership development, assay design/validation, reimbursement analysis, and operations. Shaun is regarded as a leader and a mentor for his strong commitment to inclusive, evidence based, and rational decision making that aligns with company scientific, strategic, and financial initiatives. He has a proven public-speaking track record and is an author of numerous scientific publications and licensed patents.

Shaun is a science geek and earned his PhD in Biomedical Sciences/Molecular Genetics & Medical Microbiology from the University of Florida and BS in Biology from Bucknell University. He has held adjunct research faculty appointments at Arizona State University in multiple life science departments.

Legal Cannabis: Medical, Toxicological and Public Health Implications

Neal L. Benowitz, MD

Professor of Medicine, University of California

Benowitz.jpgNeal L. Benowitz, MD, is Professor of Medicine and Bioengineering & Therapeutic Sciences, and Chief of the Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco (UCSF). He received his medical degree from the University of Rochester School of Medicine in 1969, following which he served as a resident in internal medicine at the Bronx Municipal Hospital Center from 1969 to 1971. He then completed a postdoctoral fellowship in clinical pharmacology at UCSF and joined the faculty in 1974. His research interests have focused primarily on the human pharmacology and toxicology of nicotine, and has also published a number of papers on the human pharmacology of cannabis. Dr Benowitz also maintains an active clinical practice in cardiovascular medicine and medical toxicology.

Eike Blohm, MD

Assistant Professor, University of Vermont

Blohm.jpgEike Blohm attended Johns Hopkins, class of 2012. He then went to the University of Massachusetts Emergency Medicine Residency. After, he attended the University of Massachusetts Toxicology Fellowship. 

Shelley DuTeaux, PhD, MPH

Chief, Human Health Assessment, California Department of Pesticide Regulation

DuTeaux.jpgShelley DuTeaux is Chief of the Human Health Assessment Branch in the California Department of Pesticide Regulation (DPR). In this role, Dr. DuTeaux provides oversight and guidance in the evaluation of human health effects of pesticides and the scientific basis for pesticide use, regulation, and mitigation activities in the state. She employs a staff of 35 scientists who review toxicity data and conduct risk and exposure analysis for all conventional and biochemical pesticides used in California. Prior to joining DPR, Dr. DuTeaux worked for 15 years in emergency preparedness and response for the California Department of Public Health, the California Air Resources Board, and the California Office of Environmental Health Hazard Assessment. As a subject matter expert on acute and high concentration exposures, Dr. DuTeaux evaluated toxic air releases and assessed the public health impacts of wildfires, train derailments, and industrial explosions and fires, and has contributed to federal and state response plans for chemical warfare agent release. Dr. DuTeaux has a broad range of environmental health experience including in the areas of lead poisoning prevention, solvent toxicity, and quantitative exposure analysis. She is also a former staff member at Los Alamos National Laboratory where she analyzed systemic plutonium distribution kinetics and dose reconstruction from World War II-era human studies. Dr. DuTeaux holds a BA in Communications (University of New Mexico), a Masters in Public Health (University of California, Berkeley), and a PhD in Pharmacology & Toxicology (University of California, Davis).

Matthew Fedoruk, PhD

Chief Science Officer, US Anti-Doping Agency (USADA)

Fedoruk.jpgDr. Matthew Fedoruk currently works as the Chief Science Officer at the U.S. Anti-Doping Agency (USADA). With more than 10 years of experience in anti-doping and a Ph.D. in Pathology and Laboratory Medicine,  Dr. Fedoruk also serves as a standing member of the IPC Anti-Doping Committee, the WADA TDSSA Expert Group Chair and Athlete Biological Passport (ABP) Ad-Hoc Working Group. Before joining USADA, Dr. Fedoruk worked at the Canadian Centre for Ethics in Sport (CCES) and served with the Vancouver 2010 Organizing Committee for the 2010 Olympic and Paralympic Winter Games in Canada. He currently lives in sunny Colorado Springs, Colorado, which is also known as ‘Olympic Town USA’ for being home to the U.S. Olympic Committee, the high-altitude Olympic Training Center, numerous national sport federations and USADA.

Igor Grant, MD

Distinguished Professor, UC San Diego, Department of Psychiatry

Grant.jpgDr. Grant is a neuropsychiatrist whose research and clinical interests have focused on the effect of various diseases and drugs on the brain and behavior. He has been Principal Investigator of numerous Federal and Department of Veterans Affairs grants on this topic and has over 700 scientific publications to his credit. He is Director of the Translational Methamphetamine AIDS Research Center (TMARC) funded by the National Institute on Drug Abuse (NIDA). More detail can be found at Dr. Grant’s website:

Since 2000, Dr. Grant has been Director of the State of California funded Center for Medicinal Cannabis Research (CMCR). The Center was funded following passage of California Prop 215, the “Compassionate Use Act” which envisioned providing patients under doctor supervision with access to medicinal cannabis in patients whose condition warranted it. California established the CMCR to develop a knowledge base concerning cannabis.

Headquartered at the University of California San Diego (UCSD), the Center has completed 7 short-term studies on medical cannabis in relation to neuropathic pain and muscle spasticity in Multiple Sclerosis. All the studies produced evidence of at least short term benefit of medicinal cannabis and these results have been published in the scientific literature and are available at:

Kennon Heard, MD, PhD

Professor of Emergency Medicine, University of Colorado School of Medicine

Heard.jpgKennon Heard is a Professor of Emergency Medicine and Section Chief of Medical Pharmacology and Toxicology at the University of Colorado School of Medicine. He is faulty at the Rocky Mountain Poison and Drug Center and teaches emergency medicine and toxicology at the Univeristy of Colorado Hospital and Children's Hospital Colorado. He is a Fellow of ACMT

Bradley King, PhD, MPH, CIH

Senior Industrial Hygienist, CDC/NIOSH

King.jpgBradley King is a senior industrial hygienist (IH) at the National Institute for Occupational Safety and Health (NIOSH). He joined NIOSH in 1999 as an IH in the Health Hazard Evaluation program in Cincinnati, Ohio; since 2013, he has worked in NIOSH’s Western States Division in Denver, Colorado. He holds a BS in Biology from Loyola University New Orleans, an MPH in Environmental and Occupational Health from Saint Louis University, and a PhD in Environmental Health Science from Johns Hopkins University. He received his commission as an Environmental Health Officer in the United States Public Health Service in 2002 and currently holds the rank of Captain. He received his certification in the comprehensive practice of industrial hygiene in 2005.  Bradley currently serves as a Director on the Board of Directors for the American Industrial Hygiene Association.

Michael J. Kosnett, MD, MPH, FACMT

Associate Clinical Professor, University of Colorado School of Medicine, and Colorado School of Public Health

kosnett.jpgDr. Kosnett is an Associate Clinical Professor in the Division of Clinical Pharmacology and Toxicology at the University of Colorado School of Medicine, an Associate Adjunct Professor in the Department of Environmental and Occupational Health at the Colorado School of Public Health, and an Attending Physician at the Rocky Mountain Poison and Drug Center. He is board certified in internal medicine, occupational medicine, and medical toxicology. Dr. Kosnett has held numerous leadership positions and national appointments as a medical toxicologist, including service as President of the American College of Medical Toxicology, member of the Committee on Toxicology of the National Academy of Sciences, and consultant for the US EPA, the Department of Defense, CDC, the Agency for Toxic Substances and Disease Registry, and the World Health Organization. In 2016, he received the Matthew J. Ellenhorn Award from the American College of Medical Toxicology in recognition of his career achievement.

Recently in Colorado, Dr. Kosnett has been extensively engaged in public health matters related to medical and recreational cannabis. He worked extensively with stakeholders to design and implement the first regulations nationwide requiring that cannabis products be sold in child-resistant packaging. He recently served on the Colorado Department of Revenue’s Marijuana Enforcement Division workgroups the dosage equivalency of cannabis products and their packaging and labeling requirements. He has served on the Colorado Department of Public Health and Environment Pediatric Exposure Prevention Guidelines Committee, and as a technical consultant to the state’s Retail Marijuana Public Health Advisory Committee regarding the pharmacology of cannabinoids. Dr. Kosnett has also offered scientific consultation to multiple stakeholders regarding the impact of cannabis use on workplace and transportation safety. He has spoken on the issue of cannabis-related biomonitoring and performance at national scientific meetings, including those convened by U.S. Anti-Doping Agency, the American College of Occupational and Environmental Medicine, the American College of Medical Toxicology, and the American Industrial Hygiene Association.

In April 2017, Dr. Kosnett began work as Co-Principal Investigator on a 3 year research projected funded by the Colorado Department of Public Health and Environment entitled “Comparative Assessment of Driving Impairment in Occasional versus Heavy Marijuana Users.”

Kara Lynch, PhD, DABCC

Associate Professor, University of California San Francisco

lynch.jpgDr. Kara Lynch is an Associate Professor of Laboratory Medicine at the University of California San Francisco and the Co-Director of the Core Laboratory (Clinical Chemistry and Toxicology) at Zuckerberg San Francisco General Hospital and Trauma Center. She received her PhD in Biochemistry from the University of Wisconsin and did a post-doctoral fellowship in Clinical Chemistry in the COMACC approved training program at UCSF. Her primary area of research is in Clinical Toxicology. Her laboratory conducts studies aimed at identifying and quantifying toxins, drugs of abuse and adulterants in biological specimens using mass spectrometry and correlating the findings with clinical pathologies.

Mike Lynn, MD

Assistant Clinical Professor Emergency Medicine, University of California, San Francisco; CEO and Co-Founder, Hound Labs, Inc.

Lynn.jpegMike is the CEO and Co-Founder of Hound Labs, Inc., a scientific device company which has developed and patented the Hound® marijuana breathalyzer – the world’s first handheld device for rapidly, accurately, and inexpensively measuring the level of THC in breath. A practicing emergency medicine physician and teacher at a premier trauma center in Oakland, CA, Mike is also a clinical faculty member at the University of California, San Francisco. In addition to being an ER physician, Mike worked for 10 years as a venture capitalist specializing in medical devices and biotechnology. A former White House Fellow and Fulbright Scholar with an extensive background in public policy and public health, Mike is currently a reserve deputy sheriff and a fully qualified and active SWAT team member.

Luke N. Rodda, PhD

Chief Forensic Toxicologist and Director, Forensic Laboratory Division, San Francisco Office of the Chief Medical Examiner

rodda.jpgAppointed as Chief Forensic Toxicologist & Director, Forensic Laboratory Division at the Office of the Chief Medical Examiner for the City and County of San Francisco, Dr. Rodda provides toxicological interpretation, expert court testimony & oversees all forensic division operations. He is involved with the analytical method development and validation, analysis and reporting of alcohol, drugs and poisons for over 13 years, and was a Forensic Toxicologist at the Victorian Institute of Forensic Medicine.

Dr. Rodda received a Ph.D. from the Dep of Forensic Medicine at Monash University. He obtained a Bachelor of Applied Sciences in Pharmaceutical Sciences from RMIT University with a First Class Honours in nanotoxicology research awarded.

Professional societies positions include Novel Psychoactive Substances Committee member and Young Scientist Committee member for TIAFT, Oral Fluid DUID committee member and Diversity Committee member for SOFT, Novel Psychoactive Substances Chair for CAT, and membership of CAC, FACTA, ANZFSS, and both the American and Australian AAFS societies.

As an invited Californian state-mandated Drug Impaired Driving Taskforce member, member of County Sexual Assault Response and Preventions groups, and National and regional Drug Death Expert Groups, he actively promotes harm reduction in DUID, DFSA and Drug Deaths within the community.

He holds an Assistant Adjunct Professor position at the University of California, San Francisco, and supervises students from various universities, publishes and reviews papers in peer-reviewed journals, and has presented at national & international conference proceedings.

Susan Tapert, PhD

Professor of Psychiatry, UC San Diego

Tapert.jpgDr. Tapert’s research focuses on brain development and adolescent substance use. She has led 16 NIH-funded projects, including a brain imaging study that recruited 295 youth prior to the initiation of substance use and followed them for 15 years. Dr. Tapert has significantly contributed to literature in her field, publishing 170 peer-reviewed articles in journals including American Journal of Psychiatry, Brain Imaging and Behavior, Neuropsychopharmacology, and Addiction, as well as 118 abstracts and 44 book chapters and review articles. She has been featured as a subject-matter expert in outlets such as USA Today, BBC Radio, the New York Times, National Public Radio and ABC News.

Dr. Tapert is associate director and site principal investigator for the Adolescent Brain Cognitive Development (ABCD) Study, the largest longitudinal study ever conducted on brain development and child health in the U.S. UC San Diego is the Coordinating Center for the 21 nationwide institutions partnering to recruit and track the biological and behavioral development of 11,000 children from age 9 or 10 through adolescence and into young adulthood. Dr. Tapert is scientific director and site PI for the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA), a multi-site, NIH National Institute on Alcohol Abuse and Alcoholism-funded consortium that enrolled and follows 831 youth across five sites.

2019 ACMT Annual Scientific Meeting

Badria Al Hatali, MD

Head of Poison Control Section, Ministry of Health

alhatali.pngDr Al Hatali  is the head of the poison control section,at environmental and occupational health department, at the Ministry of Health in Oman. She also serves as the Middle East and North Africa Association of Medical Toxicology (MENATOX) Treasurer. She is an Acting consultant in the Emergency Medicine Department at Royal Hospital. She  graduated from  Oman Medical Specialty Board in 2012 as well as  certified by the Arab Emergency Medicine Board. She finished her Post Doctoral Fellowship in medical toxicology at Emory University and the Georgia Poison Center  in Atlanta, GA USA in 2014. She has lectured in countries around the world and has awards to her credit. Dr Al Hatali often teaches at the Oman Medical Speciality Board in Oman and has a true passion for Toxicology.

Maryann Amirshahi, PharmD, MD, MPH

Emergency Medicine Physician, MedStar Washington Hospital Center

no_avatar.jpgMaryann Amirshahi completed her PharmD at the University of the Sciences in Philadelphia, followed by medical school at Temple University. She completed her emergency medicine residency at the Hospital of the University of Pennsylvania, medical toxicology fellowship at the George Washington University, and clinical pharmacology fellowship at Children’s National Medical Center. She also received an MPH from the George Washington University focusing on environmental and occupational health. She is board certified in emergency medicine, medical toxicology, addiction medicine, and clinical pharmacology. She is an Assoicate Professor of Emergency Medicine at the Georgetown University School of Medicine and practices clinically at MedStar Washington Hospital Center and Children’s National Medical Center. She serves as a toxicology consultant for the Mid-Atlantic Center for Children’s Health and the Environment and the National Capital Poison Center. Her research interests include medication safety, medical toxicology, drug shortages, and prescription drug abuse.

Ashish Bhalla, MD

Post Graduate Institute of Medical Education and Research

Bhalla.jpgI am Dr Ashish Bhalla, professor of Internal Medicine at post graduate institute of medical education and research, Chandigrah, a premier tertiary care medical institute in North Western India. I am an internist with more than 25 years of teaching experience in teaching undergraduates and post graduate students. i am a trained toxicologist with fellowship in clinical toxicology from St Thoma's hospital London under the guidance of Prof Paul Dargan. I have been a board member and secretary for Asia Pacific Association of Medical Toxicology (APAMT) for 4 years and am will take over as President of APAMT on 1st January 2019. i have been a member of the EXTRIP group and also the Lipid rescue group. i have published extensively in the field of organophosphates, aluminium phsophide and snake envenomation. I have been actively associated with ACMT and CDC for management of chemical emergencies and disaster training in India. I have been a visiting faculty to various universities in USA, Canada and Australia.

Rana Biary, MD

Medical Toxicology Fellowship Director, NYU/Bellevue Hospitals

biary.pngRana Biary did her Emergency Medicine residency at Cornell/Columbia and her Toxicology fellowship at NYU/Bellevue. She is currently the Medical Toxicology fellowship director at NYU where her interests include curriculum development, mentorship, and physician wellness. Having spent her most of her childhood living abroad, she identifies as a "Third Culture Kid" and loves to spend her free time traveling and meeting new people.

Paul D. Blanc, MD, MSPH

Professor of Medicine and the Endowed Chair in Occupational and Environmental Medicine, University of California San Francisco

Blanc.jpgDr. Paul D. Blanc MD MSPH is Professor of Medicine and holds the Endowed Chair in Occupational and Environmental Medicine at the University of California San Francisco. Blanc received his BA from Goddard College (Plainfield, Vermont), where he first became interested in health and the environment, later training at the Harvard School of Public Health (in industrial hygiene), the Albert Einstein School of Medicine, and Cook County Hospital (in a joint Occupational Medicine and Internal Medicine Residency). He was a Robert Wood Johnson Clinical Scholar at UCSF from 1985-7 and a Fulbright Senior Research Scholar at the Ben Gurion University of the Negev in 1987-8. He has been a resident scholar at the Rockefeller Bellagio Center (Bellagio, Italy) and the American Academy in Rome. In 2013-4, he was a fellow at the Center for Advanced Studies in the Behavioral Sciences at Stanford University. In 2016, he was awarded an Honorary Doctorate from the Sahlgrenska Medical Academy, Gothenburg, Sweden. Blanc has authored numerous scholarly publications in his field and is the author of How Everyday Products Make People Sick (University of California Press, 2009) and Fake Silk: The Lethal History of Viscose Rayon (Yale University Press, 2016 ). Fake Silk received the Viseltear Prize from the American Public Health Association, for “Outstanding Book on the History of Public Health” in 2017. Blanc also has written a blog, “Household Hazards,” hosted by the magazine Psychology Today.

Stephanie Carreiro, MD, MSPH

Assistant Professor, University of Massachusetts Medical School

Carreiro.pngStephanie Carreiro, MD is an emergency medicine physician and medical toxicologist. She is a 2009 graduate of New York Medical College and completed her Emergency Medicine Residency in 2013 at Brown University before pursuing a medical toxicology fellowship at the University of Massachusetts.   In 2015 she joined the Division of Medical Toxicology at the University of Massachusetts as an Assistant Professor of Emergency Medicine.  Dr. Carreiro has a passion for novel translational research, which she first discovered during residency while evaluating novel antidotes for cardiotoxicity in animal models.  She now focuses on the integration of wearable technology with behavioral interventions in the treatment of substance abuse disorders.   Her current research interests include the utilization of of wearable biosensors and microRNA profiles to evaluate drug toxicity, substance, abuse and addiction. She is currently a University of Massachusetts Mentored Career Development Award KL2 scholar, and is also pursuing a PhD in Biomedical Sciences from the University of Massachusetts.

Peter R. Chai, MD, MMS

Emergency Medicine Physician, Brigham and Women's Hospital

Chai.jpgDr. Peter R Chai is an Emergency Medicine Physician and Medical Toxicologist at Brigham and Women’s Hospital and Harvard Medical School, and adjunct faculty at The Fenway Institute. He is a graduate of the Warren Alpert Medical School at Brown University where he also did his residency in Emergency Medicine. After completing his fellowship in medical toxicology at the University of Massachusetts Medical School, Dr. Chai is currently funded by the National Institute on Drug Abuse to develop digital health interventions that respond to varying Pre-exposure prophylaxis adherence patterns among men who have sex with men with stimulant use. His other investigations include understanding the underlying mechanisms and use of music to address pain and opioid use, and wearable biosensors to detect changes in physiologic state among emergency department patients.

Andrew Erdman, MD

Safety Science, Senior Group Medical Director, Roche/Genentech

erdman.jpgBorn and raised in Northern California, Andrew Erdman graduated from UCLA with a BS in Kinesiology in 1992. He graduated with honors from UC Davis School of Medicine in 1996. In 1997, he completed an internship in General Surgery at St Joseph Hospital in Denver. He then completed his residency in Emergency Medicine at Denver Health Medical Center in Colorado. He finished his fellowship in Medical Toxicology at the Rocky Mountain Poison and Drug Center in Colorado in 2002 and his fellowship in Clinical Pharmacology at UCSF in San Francisco in 2005. 
Andrew Erdman was a Global Drug Safety Physician for Astra Zeneca, UK from 2005 to 2006; a Senior Drug Safety Scientist at Genentech from 2006 to 2009; a Global Safety Medical Director at Amgen from 2009 to 2011; and a Senior Group Medical Director, Early Development Safety at Genentech from 2011 to present. His interests include surfing, biking, travel, art, and food.

Brenna Farmer, MD, MSc, MBAc

Attending Physician, Weill Cornell Medicine

farmer.JPGDr. Brenna Farmer is an attending physician in the Department of Emergency Medicine at Weill Cornell Medicine. Her clinical work occurs at New York Presbyterian Hospital's Weill Cornell and Lower Manhattan Hospital campuses. She works as a consultant for the Medical Toxicology Consultation Service at both sites. Her interests include acute bedside care of the poisoned patient, adverse medication events and medication safety.

Kimberlie Graeme, MD, FACMT

Medical Toxicologist, Banner University Medical Center - Phoenix

Graeme_Kimberlie.jpgDr. Graeme is an Associate Professor of Emergency Medicine at the College of Medicine – Phoenix and the Assistant Director of the Medical Toxicology Fellowship at the Banner – University Medical Center Phoenix. Her interests include natural toxins as well as suicide and poisoning prevention.

Keith Humphreys, PhD

Esther Ting Memorial Professor, Stanford University

humphreys.jpgKeith Humphreys is the Esther Ting Memorial Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. He is also a Senior Research Career Scientist at the VA Health Services Research Center in Palo Alto and an Honorary Professor of Psychiatry at the Institute of Psychiatry, King's College, London. His research addresses the prevention and treatment of addictive disorders, the formation of public policy and the extent to which subjects in medical research differ from patients seen in everyday clinical practice.

For his work in the multinational humanitarian effort to rebuild the psychiatric care system of Iraq and in the national redesign of the VA health system's mental health services for Iraq war veterans, he won the 2009 American Psychological Association Award for Distinguished Contribution to the Public Interest. He and the authors of "Drug Policy and the Public Good" won the 2010 British Medical Association's Award for Public Health Book of the Year.

Dr. Humphreys has been extensively involved in the formation of public policy, having served as a member of the White House Commission on Drug Free Communities, the VA National Mental Health Task Force, and the National Advisory Council of the U.S. Substance Abuse and Mental Health Services Administration. During the Obama Administration, he spent a sabbatical year as Senior Policy Advisor at the White House Office of National Drug Control Policy. He has also testified on numerous occasions in Parliament and advises multiple government agencies in the U.K.

Sam Jackson, MD

Vice President of Translational Medicine, Audentes Therapeutics

no_avatar.jpgComing soon.

Bryan Judge, MD

Medical Toxicologist, Emergency Care Specialists

Judge_Photo.jpgBryan Judge practices Emergency Medicine and Medical Toxicology in Grand Rapids, MI and Emergency Medicine in Laurium, MI. He is currently an Associate Professor in the Department of Emergency Medicine, College of Human Medicine - Michigan State University.

Vikas Kapil, DO, MPH

Chief Medical Officer and Associate Director, Center for Global Health, Centers for Disease Control and Prevention

Kapil.pngDr. Vikas Kapil is the Chief Medical Officer and Associate Director for Science at CDC’s Center for Global Health. Previously he was at the National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (NCEH/ATSDR) where he served in several roles as part of the senior management team, including as Associate Director and Chief Medical Officer. He currently oversees CDC’s initiative on household air pollution and health and a long standing collaboration on environmental and occupational health and injury prevention and control with the Government of India. He served previously as Associate Director for Science for the Division of Injury Response at CDC’s National Center for Injury Prevention and Control (NCIPC), and as the Branch Chief for the Surveillance and Registries Branch at the Agency for Toxic Substances and Disease Registry (CDC/ATSDR). His clinical and research interests include environmental and occupational pulmonary diseases, environmental emergencies, and occupational toxicology.

Dr. Kapil attended medical school at Michigan State University, College of Osteopathic Medicine (D.O.) and received a Master in Public Health (MPH) from the University of Michigan. He completed residency training in Emergency Medicine at POH Medical Center in Pontiac, Michigan and Fellowship in Occupational and Environmental Medicine at the University of Michigan Medical Center in Ann Arbor, Michigan. He is Board Certified in Emergency Medicine and Preventive Medicine and maintains licenses to practice in Ohio and Georgia. He holds adjunct academic faculty appointments at the University of Cincinnati, Department of Environmental Health and Emory University, Department of Emergency Medicine in Atlanta.

JoAn Laes, MD

Addiction Medicine Physician, Hennepin Healthcare

Laes.pngJoAn Laes, MD, Attending Physician, Division of Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN; Core Medical Toxicology Faculty, Minnesota Poison Control System, Minneapolis, MN; Medical Director, Mission Detox Center, Plymouth, MN and 1800 Detox, Minneapolis, MN, ASAM Medical Toxicology Workgroup Chair, ACMT Addiction Medicine Committee Co-chair
Dr. Laes' practice is focused on inpatient addiction medicine and toxicology consultation and outpatient treatment of opioid and other substance use disorders. She is board certified in Internal Medicine, Addiction Medicine, and Medical Toxicology. She completed internal medicine residency at Hennepin Healthcare and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

Rama B. Rao, MD, FACMT

Associate Professor, Weill Cornell Medical College NYP

Rao.pngRama B. Rao is the Chief of the Division of Medical Toxicology at the New York Presbyterian Hospital and associate professor at the Weill Cornell Medical College.  She serves as Chair of AACT Forensic Special Interest Group, served on the American Board of Emergency Medicine Sub-board in Medical Toxicology, and has presented the annual assemblies of ACMT, AACT and EAPCCT.

Anne-Michelle Ruha, MD

Vice Chair Department of Medical Toxicology, Banner - University Medical Center Phoenix

ruha.bmpDr. Michelle Ruha is Vice Chair of the Department of Medical Toxicology at Banner – University Medical Center in Phoenix, Arizona. She is a Professor with the Departments of Internal Medicine and Emergency Medicine at the University of Arizona College of Medicine – Phoenix. Her clinical practice is focused on the acute care of patients with poisoning, envenomation and illness related to substance misuse disorders. She serves as faculty for both the Medical Toxicology and Addiction Medicine fellowships at the College of Medicine in Phoenix. Dr. Ruha is currently the Vice President of the American College of Medical Toxicology and the Associate Editor for the Journal of Medical Toxicology.

Veena Singla, PhD

Associate Director, Science & Policy, University of California, San Francisco Program on Reproductive Health and the Environment

no_avatar.jpgVeena Singla, PhD, is Associate Director of Science & Policy at the Program on Reproductive Health and the Environment. Her work focuses on informing policies with the most current scientific principles and data to reduce and prevent harmful environmental exposures. Her research focuses on indoor environmental quality and how exposure to multiple chemicals affects health outcomes, especially for vulnerable populations such as workers, pregnant women and young children. She specializes in the communication of complex scientific information at the intersection of research and policy, and has led work on groundbreaking policies which attempt to establish frameworks for safer chemical evaluation and substitution. She worked as a postdoctoral teaching fellow at Stanford University and as an adjunct faculty member at the University of San Francisco. She holds a bachelor’s degree from the University of California, Berkeley, and a PhD in cell biology from the University of California, San Francisco.

Aaron Skolnik, MD

Senior Associate Consultant, Department of Critical Care Medicine, Mayo Clinic

no_avatar.jpgAaron Skolnik received his MD from the University of Pittsburgh School of Medicine and completed residency in emergency medicine at Brigham and Women’s/Massachusetts General Hospital in Boston, MA. Thereafter, Aaron graduated from the medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ. He served as co-medical director of the Banner Poison and Drug Information Center and on the faculty of the University of Arizona College of Medicine, Phoenix. Subsequently, he completed additional fellowship training at the University of Pittsburgh in Critical Care Medicine and Neurocritical Care. He currently works as a multidisciplinary intensivist at the Mayo Clinic Arizona. He is board certified/eligible in Emergency Medicine, Medical Toxicology, Addiction Medicine, Critical Care Medicine, and Neurocritical Care.

Samuel J. Stellpflug, MD, FACMT

Director, Clinical Toxicology; Associate Professor of Emergency Medicine, Regions Hospital

Stellpflug.jpgSam is the Director of the Regions Hospital Clinical Toxicology Service (Saint Paul, MN) and the Twin Cities Med Tox Fellowship. He also practices, teaches, and learns as a faculty physician in the Regions Department of Emergency Medicine. He provides consultation for the Minnesota Poison Control System, and his academic appointment is through the University of Minnesota Medical School. Following medical school at the University of Wisconsin he completed a residency in emergency medicine at Regions Hospital and then the medical toxicology fellowship in the Twin Cities, a joint effort between the Regions Hospital / HealthPartners and the Minnesota Poison Control System. Sam's research interest is in treatment of poison-induced cardiogenic shock, among other things.

Ross Sullivan, MD

Fellowship Director - Medical Toxicology, SUNY Upstate Hospital and Poison Center

Pic_Sullivan_Ross.jpgRoss Sullivan, originally from Buffalo, NY, completed his medical school education at SUNY Upstate Medical University. After, he finished an Emergency Medicine Residency (2008) and a Toxicology Fellowship (2011) at the SUNY Upstate Emergency Department. Dr. Sullivan is also board certified in Addiction Medicine.

Dr. Sullivan is currently the fellowship director of Medical Toxicology program at UH. He also is the director of the Upstate Emergency Opioid Bridge Clinic, as well as the medical director for Helio Health, Inc.

Dr. Sullivan currently is a member of the Medical Advisory Panel to OASAS (Office of Alcoholism and Substance Abuse in NYS), the NYDOH buprenorphine work group, and member of Onondaga County Drug Task Force. Dr. Sullivan also was an invitee to a US Congressional Panel on the topic of emergency addiction care, as well as a contributing author of a to- be published compendium developed by the Office of National Drug Control Policy, part of the Executive Office of the President.

Javier Waksman, MD

Executive Medical Director, FibroGen, Inc.

no_avatar.jpgComing soon.

Paul Wax, MD, FACMT

Executive Director, American College of Medical Toxicology

Wax_Paul.jpgDr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.
Along with his part time role as the Executive Director of ACMT, Dr. Wax is a Clinical Professor in Surgery (Emergency Medicine) at the University of Texas, Southwestern School of Medicine where he is a member of the Section of Medical Toxicology and Director of the Medical Toxicology Clinic. Before joining ACMT in 2008 as its Executive Director, and the University of Texas Southwestern in 2006 as a part-time faculty member, Dr. Wax had faculty appointments in the Departments of Emergency Medicine at the University of Rochester School of Medicine from 1991-2001 and the University of Arizona School of Medicine from 2001-2006. Dr. Wax previously served on the Board of Directors of ACMT from 1998-2008 serving as ACMT President from 2006-2008. During this tenure he chaired the ACMT Education Committee from 1998-2002. From 2002-2006 Dr. Wax served as the National Director of ACMT's Consultation Network to support the ATSDR Regional Offices and was co-founder of ACMT’s Chemical Agent of Opportunity course. From 1997-2006 Dr. Wax also served as one of the American Board of Emergency Medicine’s appointee’s on the Medical Toxicology Subboard. During this time Dr. Wax served as Editor of the Medical Toxicology Board Certification Examination as well as Chairman of the Subboard, and was also the primary author of the 2004 Core Content of Medical Toxicology. Dr. Wax has also served as a consultant to the Centers for Disease Control NCEH’s Division of Laboratory Sciences and was a member of NCEH/ATSDR Board of Scientific Counselors from 2006-2008.  

Tim Wiegand, MD, FACMT

Associate Professor of Emergency Medicine, University of Rochester Medical Center

Wiegand_Timothy.jpgTim Wiegand MD, DABAM, FACMT, FAACT attended Iowa State University and graduated with Honors and Distinction in 1995. He received his MD from the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin in 2004. Dr. Wiegand completed a categorical Internal Medicine residency at Hennepin County Medical Center, Minneapolis, Minnesota and completed fellowship training in Medical Toxicology and Clinical Pharmacology at the University of California, San Francisco in 2006 and 2007 respectively. Dr. Wiegand also became Board Certified in Addiction Medicine in 2015. He was the Medical Director of the Rochester Poison Center until 2010 and currently serves as the Director of Toxicology and of the Toxicology Consult Service at the University of Rochester Medical Center. Dr. Wiegand is an Associate Clinical Professor in the Department of Emergency Medicine at URMC and also a volunteer faculty member of the SUNY Upstate Medical Toxicology Fellowship program. Dr. Wiegand's research interests include billing, reimbursement and effectiveness of Medical Toxicology practice models, warning signs for suicide attempt in particular the use and involvement of alcohol or drugs in a suicide attempt and he is involved with wide variety of surveillance and research projects involving the bedside toxicology Registry the ACMT Toxic Case Registry.